Aug 23, 2018 virotherapy is an emerging branch of medicine which explores the use of viruses to kill cancers. Malignant glioma is the most common primary brain tumor and carries a grim prognosis, with a median survival of just over 14 months. Pdf oncolytic virotherapy of canine and feline cancer. Yin j, markert jm and leavenworth jw 2017 modulation of the intratumoral immune landscape by oncolytic herpes simplex virus virotherapy. Current limitations exist, however, for oncolytic virotherapy. Its ability to evade detection and adapt to various cancer therapies means that it is a moving target that becomes increasingly difficult to attack. Vaccineattenuated strains of measles virusmvis an ideal candidate for oncolytic virotherapy which has an excellent safety record. This study incorporates the innate immune response into our basic model for virotherapy and investigates how the innate immunity affects the outcome of virotherapy. Il15 as the t cell activating stimulus and a prostaglandin synthesis inhibitor as the antiimmunosuppressant were combined with adoptive transfer of tumorspecific t cells. Oncolytic virotherapy of canine and feline cancer core. Both viral proteins and chimeric fcu1 protein could be detected in tumor tissue 2 d following 1 or 2 injections of virus.
Oncolytic virotherapy is based on the development of replicationcompetent viruses that have the ability to selectively replicate within and kill tumor cells. Design and application of oncolytic viruses for cancer immunotherapy. Virotherapy treatment how it works for mesothelioma. Disabling two viral genes enhances tumor selectivity. Pdf oncolytic virus therapy is perhaps the next major breakthrough in cancer treatment following the success in immunotherapy using. The approval of the first oncolytic virus ov for the treatment of metastatic. Hematological malignancies such as leukemias, lymphomas, multiple myeloma mm, and the myelodysplastic syndromes mdss primarily affect adults and are difficult to treat. In this study, the oncolytic potential of the attenuated vaccine strain leningrad16 l16 of mv was evaluated in a panel of human metastatic melanoma cell lines. Oncolytic virotherapy 3 injections at a 3d interval started 12 d after injection of renca cells in the renal capsule of balbc mice. As diligent scientists search for powerful oncolytic viruses, the field of virotherapy seems destined to continue to expand.
Oncolytic virotherapy with an armed vaccinia virus in an. Identification and characterization of alphavirus m1 as a. Oct 22, 2019 improving efficacy of oncolytic virotherapy remains challenging due to difficulty increasing specificity and immune responses against cancer and limited understanding of its population dynamics. Oncolytic virus not only possesses unique mechanisms of action that are distinct from other treatment modalities, its selfperpetuating nature provides an ideal. The viral infection also stimulates the bodys immune system to eliminate the infected cancer cells, potentially causing malignant tumors to shrink. Sep 23, 2015 oncolytic virotherapy mechanism of action. Oncolytic viruses, including live attenuated measles virus mv vaccine strains, have recently been shown as promising therapeutic agents against human malignancies. Pde model for oncolytic virotherapy including the required initial conditions ics and boundary conditions bcs. The oad potency could be increased by chemotherapyinduced autophagy, an intracellular degradation system that delivers cytoplasmic constituents to the lysosome. A novel oncolytic virotherapy using liveattenuated. Oncolytic virotherapy means the elimination of malignant cells by viral propagation inside the tumor. Cancer virotherapy volume 1 issn 22560920 interactive pdf version 208 mb. Oncolytic virotherapy a novel strategy for cancer therapy. Oncolytic virus therapy shows benefit in patients with.
Yokoda r, nagalo bm, arora m, egan jb, bogenberger jm, deleon tt, zhou y, ahn dh, borad mj. Types of virotherapy include oncolytic virotherapy, viral immunotherapy and viral vectors, which is also called viral gene therapy. Here, we intend to update the progress made in the last five years and to. Oncolytic virotherapy is an emerging treatment modality which uses replication competent viruses to destroy cancers. Oncolytic virotherapy is a selective and powerful tool for cancer treatment. Side effects may vary according to the type of oncolytic virusand what exactly it targetsand may also be influenced by.
We hypothesized that the intratumoral administration of an oncolytic virus optimized to attract immune cells might favorably change the tumor microenvironment in the injected lesions and. Remission of disseminated cancer after systemic oncolytic. Russell, md, phd, center on demonstrating the value of oncolytic virotherapy as a new modality for the treatment of cancer. Oncolytic virotherapy exploits the properties of human viruses to naturally cytolysis of cancer cells. A new era in cancer treatment rigvir is the first, not genetically modified, nonpathogenic live virus to be registered as a drug and used by oncologists. Oncolytic virotherapy may be a promising approach to treat tnbc. Following the first description of a virus engineered to replicate selectively in dividing cells almost a decade ago,2 the field of viral therapy for cancer virotherapy. Oncolytic virotherapy is a new strategy to reduce tumor burden through selective virus replication in rapidly proliferating cells.
This particular oncolytic virus is based on herpes simplex virus type 1 and has been modified to include a gene that codes for gmcsf, a protein that stimulates the production of immune cells in the body. Virotherapy is cancer treatment using a virus to find and destroy cancer cells without harming healthy cells. Modulation of the intratumoral immune landscape by oncolytic. Oncolytic virotherapy accessscience from mcgrawhill education.
Virotherapy is a treatment using biotechnology to convert viruses into therapeutic agents by reprogramming viruses to treat diseases. By permitting replication and viralinduced cell lysis, multiple successions of viral particle release, infection, and. The use of vv for oncolytic virotherapy is regarded as very safe and generally only causes mild, flulike symptoms. Viruses can be designed with biological specificity to infect. Progress in oncolytic virotherapy for the treatment of.
Oncolytic virus therapy cancer research institute cri. Learn more about virotherapy today to see if this is the best form of treatment for you or a loved one. The approval of the first oncolytic virus ov for the treatment of metastatic melanoma and the recent discovery that the use of oncolytic viruses may enhance. Both these ovs are restricted to intratumoral administration into cancer lesions. Oncolytic virotherapy is a new modality of cancer treatment which uses competent replicating viruses to destroy cancer cells.
It uses a twopronged mechanism of action against cancer. They include the bodys b and t cell responses, innate inflammatory reactions, host range, safety risks involved in using modified viruses as treatments, and the requirement that most currently available oncolytic viruses require local. As a clinical setting in which local live biological therapy is already well established, nonmuscle invasive bladder cancer nmibc presents intriguing opportunities for oncolytic virotherapy. Oncolytic virotherapy method of lines pde analysis in. Oncolytic virotherapy is a growing treatment modality that uses replicating viruses as selective antineoplastic agents. Oncolytic virotherapy for cancer treatment international. Engeland this book aims to provide a guide for virologists, translational researchers, and clinicians in the field of cancer research by providing reference protocols and methodologies from vector development through clinical translation. Review the oncolytic virotherapy treatment platform for. Oncolytic viruses workshop 6 may 11, 2020 stephen j. Jul 10, 2012 oncolytic virotherapy is an emerging treatment modality that uses replicationcompetent viruses to destroy cancers.
Pdf oncolytic virotherapy stephen bradley academia. These branches utilize three different types of treatment methods. Concept of oncolytic virotherapyclinical implementation. The nature of viral delivery, infection, and replication makes oncolytic virotherapy valuable for treating cancer patients, especially those with inoperable tumors. Pdf oncolytic virotherapy using herpes simplex virus. However, oncolytic adenovirus oadbased monotherapeutic clinical trials have resulted in modest outcomes. The relative safety of hsv coupled with extensive knowledge on how hsv interacts with the host has provided a platform for manipulating hsv to enhance the targeting and killing of. Developing genetically engineered oncolytic viruses for. However, if we are to stand a chance in this war against cancer. A first in human phase 1 study of cg0070, a gmcsf expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer. Oncolytic virotherapy is an emerging technology that uses engineered viruses to treat malignancies.
Oncolytic virotherapy promotes intratumoral t cell. Russell, md, phd the research interests of stephen j. The phase 1b trial included a baseline biopsy before initiation of intratumoral talimogene laherparepvec injections, with a first injection of up to 4 ml. Coxsackievirus a21 cva21 is a novel intercellular adhesion molecule1 icam1targeted immunotherapeutic virus. We hypothesized that the combination of a local stimulus for activating tumorspecific t cells and an antiimmunosuppressant would improve treatment of gliomas. Allison4 preexisting lymphocytic infiltration of tumors is associated with. Oncolytic virotherapy journal of oncolytic virotherapy. Given the poor outcomes with standardofcare treatments, novel treatment strategies are needed. Oncolytic virotherapy for canine and feline cancers many wild type or recombinant viruses have been tested as oncolytic agents for treatment of canine or feline cancer.
Mesenchymal stem cells mscs loaded with oncolytic viruses are presently being investigated as a new modality of advancedmetastatic tumors treatment and enhancement of virotherapy. Localized oncolytic virotherapy overcomes systemic tumor. Synergistic combination of oncolytic virotherapy and. Oncolytic virus ov therapy is based on selective replication of viruses in cancer cells and their subsequent spread within a tumor without causing damage to. Oncolytic viruses that is, viruses that destroy cancer cells, but not normal cells are able to infect, replicate inside of, and kill cancer cells through diverse mechanisms. The role of the innate immune system in oncolytic virotherapy. Oncolytic virotherapy is still ongoing clinical trials 49, 3, and some virusdrug com bos, for example talimogene laherparepvec, have been approved for the. Our new yale medicineyale new haven health covid19 call center offers information on how to keep yourself and your family healthy. Oncolytic virotherapy is a new strategy to reduce tumor burden through selective virus replication in proliferating cells. Patil, ivan petrov, joseph cappello, marion adelfinger and aladar a.
They include human and canine adenoviruses, canine distemper virus cdv, reovirus and members of the poxvirus family such as vaccinia virus, recombinant canary poxvirus alvac. The viral therapeutic dynamics is largely determined by the viral burst size, relative innate immune killing rate, and relative innate immunity. Virotherapy is an emerging branch of medicine which explores the use of viruses to kill cancers. Oncolytic virotherapy for hematological malignancies. Design and application of oncolytic viruses for cancer. Oncolytic virotherapy for pancreatic cancer expert. Oncolytic adenovirus programmed by synthetic gene circuit for. Oncolytic virotherapy for the treatment of malignant glioma. Oncolytic virotherapy promotes intratumoral t cell infiltration and improves antipd1 immunotherapy. This chapter pertains to a mathematical model for cancer therapy based on the use of viruses, that is, oncolytic virotherapy immunotherapy, immuno. For highrisk disease, hematopoietic stem cell transplant hct can be used. Oncolytic virotherapy is an exciting, increasingly recognized discipline in cancer research. Oncolytic virus not only possesses unique mechanisms of action that are distinct from other treatment modalities, its selfperpetuating nature provides an ideal platform for.
Oncolytic virotherapy the use of oncotropic oncolytic viruses in oncology is called oncolytic virotherapy. Collectively, these patients provided heretofore unreported insights into the feasibility and risktobene. Kirchenstein institute of microbiology and virology, riga stradins university. The potential of replication competent oncolytic viruses rcovs has only recently started to be realized. Through technological advancements, we have developed sophisticated weapons to fight off tumor growth and invasion. Oncolytic virotherapy in upper gastrointestinal tract cancers. The human pathogen herpes simplex virus hsv has proven particularly amenable for use in oncolytic virotherapy. Mesenchymal stem cells used as carrier cells of oncolytic. A novel oncolytic virotherapy using liveattenuated poliovirus for soft tissue sarcoma 1 atsumi, s. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasnt until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. This field progressed from earlier observations of accidental viral infections causing remission in many malignancies to virus drugs targeting and killing cancer cells. Oncolytic virotherapy is a promising anticancer strategy, because it can provide a local regional control, or eradication of tumors without crossinterference with standard therapies. Tvecs fda approval was undoubtedly a great milestone for the. They have undergone different modifications to enhance tumor selectivity, improve intratumoral replication.
Health professionals are available to answer your questions, monday friday, 7 am 7 pm. Advances in the past two years include preclinical proof of feasibility for a singleshot virotherapy cure, identification of drugs that accelerate intratumoral virus propagation, new strategies to maximize the immunotherapeutic potential of oncolytic virotherapy, and clinical. The advantages of virotherapy include the potential lack of cross resistance with standard therapies and the ability to cause tumor destruction by numerous mechanisms. However, in the setting of autologous hct, relapse due to contamination of the autograft with cancer cells remains a major challenge. Oncolytic virotherapy is an emerging treatment modality that uses replicationcompetent viruses to destroy cancers. Oncolytic immunotherapy for bladder cancer using coxsackie.
It appears you dont have adobe reader or pdf support in this web browser. Cancer is a traitorous archenemy that threatens our survival. Subudhi,4 joon seok park,5,6 mena mansour,7,8 peter palese,7 taha merghoub,1,3 jedd d. Recently, arming oncolytic viruses with immunomodulatory molecules has been a major focus in virotherapy. The complexity of the immune responses is a major challenge in current virotherapy. Safety and efficacy considerations dictate that an ideal oncolytic agent would discriminate between normal and cancer cells on the basis of common genetic abnormalities in human cancers. The concept of virotherapy for the treatment of malignant tumors dates back more than a century and can be divided into replicationcompetent oncolytic viruses and. Oncolytic virotherapy is a relatively new therapeutic modality which seeks to turn the cytolytic ability of replicating viruses against cancerous cells, while sparing nonin vivo cancerous cells. Cancer virotherapy 3 cancer virotherapy rigvir rigvir.
The primary clinical milestone has been completion of accrual in a phase 3 trial of intratumoral herpes simplex virus therapy using talimogene laherparepvec for. Oncolytic virotherapy, the concept of treating cancer with viruses, is an important mechanism that provides an emerging opportunity in the struggle against cancer in recent past and nowadays. There is currently one oncolytic virus therapy approved by the fda for the treatment of cancer. Oncolytic virotherapy of canine and feline cancer by ivaylo gentschev, sadeep s. Recent advances include preclinical proof of feasibility for a singleshot. Poxvirus oncolytic virotherapy oncomyx therapeutics. Viruses from several families are engineered in dr.
Immune suppression during oncolytic virotherapy for high. Advances in the past two years include preclinical proof of feasibility for a singleshot virotherapy cure, identification of drugs that. Properties of the three best studied family of oncolytic viruses used in clinical trials. Oncolytic virotherapy journal of vascular and interventional. Tvec is an oncolytic virus, a virus that selectively replicates inside and kills cancer cells. Oncolytic myxvs have been tested in a wide variety of animal tumor models, proving its effectiveness as virotherapy against many types of cancers 14. Oncolytic virotherapy dove press open access publisher. Oncoselectivity in oncolytic viruses against colorectal cancer. Oncolytic viruses and their application to cancer immunotherapy. This form of therapy is now the leading treatment used to delay the spread of mesothelioma. Abstract oncolytic virotherapy ovt is a novel form of immunotherapy using natural or genetically modi.
79 445 1205 1484 1019 390 20 1010 233 97 528 422 23 383 1046 1215 517 123 607 1069 1061 1413 116 636 877 1183 1469 1062 684 1118 231 1496 227 187